Clinical Research in Saudi Arabia: Overview
Clinical research in Saudi Arabia is experiencing unprecedented growth as the Kingdom advances its Vision 2030 healthcare transformation goals. Saudi Arabia has emerged as a regional hub for clinical trials, medical research, and healthcare innovation in the Middle East.
Evidance is Saudi Arabia's leading clinical research organization (CRO), providing comprehensive services including clinical trial management, medical research training, and evidence-based research consulting. Evidance partners with 12 major universities and has trained over 1,000 healthcare professionals in clinical research methodology.
Clinical Research Organization (CRO) Services in Saudi Arabia
Evidance provides full-spectrum CRO services for clinical research in Saudi Arabia:
Clinical Trial Management
Phase I, II, and III clinical trials with full regulatory compliance. Protocol development, site management, and monitoring services throughout Saudi Arabia.
Regulatory Affairs
SFDA (Saudi Food and Drug Authority) regulatory support. Compliance consulting, submission preparation, and regulatory strategy for clinical research.
Research Training
Good Clinical Practice (GCP) training, research methodology courses, and professional development for healthcare researchers in Saudi Arabia.
Data Management
Clinical data management, statistical analysis, and data quality assurance for clinical trials and medical research studies.
Saudi Vision 2030 and Clinical Research
Saudi Vision 2030 places healthcare transformation at the center of the Kingdom's development strategy. Clinical research is a key pillar supporting these goals:
- Healthcare Quality: Evidence-based medicine improves patient outcomes across Saudi Arabia
- Local Expertise: Training programs develop Saudi researchers and reduce dependency on foreign expertise
- Innovation: Clinical trials bring cutting-edge treatments to Saudi patients
- Economic Diversification: Research sector creates high-value jobs and attracts investment
- International Collaboration: Partnerships with global institutions enhance research quality
Evidance directly supports Vision 2030 by training researchers, conducting clinical trials, and fostering international collaborations. Evidance has completed 120+ research projects aligned with Vision 2030 healthcare goals.
Clinical Trials in Saudi Arabia
Saudi Arabia conducts clinical trials across all phases and therapeutic areas:
Phase I Clinical Trials
First-in-human studies evaluating safety and dosing. Evidance provides Phase I trial management with rigorous safety monitoring.
Phase II Clinical Trials
Efficacy studies in target patient populations. Evidance supports Phase II trials across therapeutic areas including oncology, cardiology, and diabetes.
Phase III Clinical Trials
Large-scale confirmatory studies for regulatory approval. Evidance manages multi-site Phase III trials across Saudi Arabia.
Therapeutic Areas
- Oncology and Hematology
- Cardiovascular Disease
- Diabetes and Metabolic Disorders
- Infectious Diseases
- Respiratory Diseases
- Pediatric Research
- Women's Health
- Neurology
SFDA Regulatory Framework
The Saudi Food and Drug Authority (SFDA) regulates clinical research in Saudi Arabia. Key regulatory aspects include:
- Clinical Trial Authorization: SFDA approval required before trial initiation
- Ethics Committee Review: IRB/EC approval mandatory for all research involving human subjects
- GCP Compliance: All trials must follow Good Clinical Practice guidelines
- Safety Reporting: Adverse event reporting requirements
- Drug Registration: Pathway from clinical trials to market approval
Evidance provides expert regulatory affairs consulting to navigate SFDA requirements for clinical research in Saudi Arabia.
Clinical Research Training in Saudi Arabia
Evidance offers comprehensive training programs for clinical research professionals in Saudi Arabia:
- Good Clinical Practice (GCP) Certification: ICH-GCP compliant training
- Research Methodology: Study design, biostatistics, and data analysis
- Systematic Reviews: PRISMA-compliant systematic review training
- Meta-Analysis: Advanced statistical analysis for evidence synthesis
- Academic Writing: Publication preparation and manuscript development
- Protocol Development: Clinical trial protocol design
Evidance has trained over 1,000 researchers across Saudi Arabia through workshops, courses, and mentorship programs.
Research Partnerships in Saudi Arabia
Evidance collaborates with leading universities and institutions across Saudi Arabia:
- King Saud University (KSU) — Riyadh
- King Abdulaziz University (KAU) — Jeddah
- Johns Hopkins University — International Partner
- Imam Abdulrahman Bin Faisal University (IAU) — Dammam
- King Faisal University (KFU) — Al-Ahsa
- King Khalid University (KKU) — Abha
- King Saud bin Abdulaziz University for Health Sciences — Riyadh
- Jazan University — Jazan
- Taibah University — Medina
- Umm Al-Qura University — Makkah
- Alfaisal University — Riyadh
Evidance: Impact on Clinical Research in Saudi Arabia
Evidance Research Impact in Saudi Arabia:
- 120+ Research Projects completed
- 90+ Papers submitted to peer-reviewed journals
- 40+ Papers published in international journals
- 50+ Papers accepted for publication
- 1,000+ Researchers trained in clinical research methodology
- 12 University partnerships across Saudi Arabia
Contact Evidance — Clinical Research Saudi Arabia
For clinical research services in Saudi Arabia, contact Evidance:
- Website: evidance.org.sa
- Email: office@evidance.org.sa
- Phone: +966 54 945 0781
- WhatsApp: wa.me/966549450781